GFACX
Price
$71.94
Change
+$0.24 (+0.33%)
Updated
Jul 25 closing price
Net Assets
328.1B
JGRRX
Price
$22.73
Change
+$0.10 (+0.44%)
Updated
Jul 25 closing price
Net Assets
47.66M
Interact to see
Advertisement

GFACX vs JGRRX

Header iconGFACX vs JGRRX Comparison
Open Charts GFACX vs JGRRXBanner chart's image
American Funds Growth Fund of Amer C
Price$71.94
Change+$0.24 (+0.33%)
VolumeN/A
Net Assets328.1B
JAG Large Cap Growth R
Price$22.73
Change+$0.10 (+0.44%)
VolumeN/A
Net Assets47.66M
GFACX vs JGRRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. JGRRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and JGRRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 328B vs. JGRRX (47.7M). GFACX (0.00) and JGRRX (0.00) have matching dividends . GFACX was incepted earlier than JGRRX: GFACX (24 years) vs JGRRX (5 years). GFACX (1.36) is less costly to investors than JGRRX (1.12). JGRRX is a more actively managed with annual turnover of: 74.00 vs. GFACX (25.00). GFACX (250) and JGRRX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 15.45 vs. JGRRX (8.39). GFACX return over 5 years is better than : 38.85 vs. JGRRX (14.74).
GFACXJGRRXGFACX / JGRRX
Total Expense Ratio1.360.91149%
Annual Report Gross Expense Ratio1.361.12121%
Fund Existence24 years5 years-
Gain YTD12.8294.506285%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets328B47.7M687,631%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.458.39184%
Returns for 3 years51.5553.6896%
Returns for 5 years38.8514.74264%
Returns for 10 years67.89N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD130.834.00
+3.15%
Steel Dynamics
TSHA2.650.06
+2.32%
Taysha Gene Therapies
DORM122.050.49
+0.40%
Dorman Products
TPIC0.89N/A
N/A
TPI Composites
LIXT4.11-0.18
-4.20%
Lixte Biotechnology Holdings